Recent Updates
Recently added Catalysts
JAZZ

Jazz Pharmaceuticals Announces Webcast for World Sleep Congress Investor Update Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, September 25, 2019 at 9:00 p.m. EDT/2:00 a....

Key Takeaway: DUBLIN , Sept. 18, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the company will host a webcast on Wednesday, September 25, 2019 at 9:00 p.m. EDT /2:00 a.m. IST ( September 26 , 2019) to provide investors with a business update, including dat

Full Press Release Details

DUBLIN , Sept. 18, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the company will host a webcast on Wednesday, September 25, 2019 at 9:00 p.m. EDT /2:00 a.m. IST ( September 26 , 2019) to provide investors with a business update, including data being presented on JZP-258 and solriamfetol at the World Sleep Congress, to be held in Vancouver, B.C. September 20-25, 2019 .
A live audio webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com . Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for at least one week.
Audio webcast/conference call: U.S. Dial-In Number: +1 855 353 7924 International Dial-In Number: +1 503 343 6056 Passcode: 4685113
A replay of the conference call will be available through October 2, 2019 and accessible through one of the following telephone numbers, using the passcode below:
Replay U.S. Dial-In Number: +1 855 859 2056 Replay International Dial-In Number: +1 404 537 3406 Passcode: 4685113
Jazz Pharmaceuticals Contacts:
Investors: Kathee Littrell Vice President, Investor Relations Ireland, +353 1 634 7887 U.S., +1 650 496 2717 Media: Jacqueline Kirby Vice President, Corporate Affairs & Government Relations Ireland, +353 1 697 2141 U.S., +1 215 867 4910
SOURCE Jazz Pharmaceuticals plc

Related Links

21 %

Last updated: Sep 18, 2019